PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 62 filers reported holding PLIANT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $644,788 | -64.5% | 37,185 | -62.9% | 0.00% | – |
Q2 2023 | $1,816,004 | -10.8% | 100,221 | +31.0% | 0.00% | – |
Q1 2023 | $2,035,485 | +394.4% | 76,522 | +259.2% | 0.00% | – |
Q4 2022 | $411,748 | -72.0% | 21,301 | -69.7% | 0.00% | – |
Q3 2022 | $1,470,000 | +1236.4% | 70,357 | +413.6% | 0.00% | – |
Q2 2022 | $110,000 | -12.0% | 13,699 | -23.2% | 0.00% | – |
Q1 2022 | $125,000 | -64.3% | 17,836 | -31.1% | 0.00% | – |
Q4 2021 | $350,000 | +7.0% | 25,876 | +33.3% | 0.00% | – |
Q3 2021 | $327,000 | +30.3% | 19,408 | +125.0% | 0.00% | – |
Q2 2021 | $251,000 | -7.0% | 8,624 | +25.8% | 0.00% | – |
Q1 2021 | $270,000 | +357.6% | 6,856 | +166.1% | 0.00% | – |
Q4 2020 | $59,000 | +321.4% | 2,576 | +313.5% | 0.00% | – |
Q3 2020 | $14,000 | – | 623 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |